Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
RALEIGH, N.C., Sept. 25, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its third quarter results after the market closes on Wednesday, October 31, 2018. The Company...
-
RALEIGH, N.C., Aug. 07, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (the “Company”) (NASDAQ: PRAH) today announced the pricing of the previously announced secondary offering of shares of its...
-
RALEIGH, N.C., Aug. 06, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (the “Company”) (NASDAQ: PRAH) today announced that an affiliate of, or a fund sponsored by, Kohlberg Kravis Roberts &...
-
Net new business of $670.0 million; Net book-to-bill of 1.30$722.8 million of revenue; 35.4% growth at actual foreign exchange rates and 34.2% growth on a constant currency basis$575.0 million of...
-
RALEIGH, N.C., July 12, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) will release its second quarter results after the market closes on Wednesday, August 1, 2018. The Company...
-
RALEIGH, N.C., May 24, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc., (PRA) (NASDAQ:PRAH) se complace en anunciar que ha sido reconocida por PharmaTimes como la Compañía Internacional de...
-
RALEIGH, N.C., May 25, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) sukacita mengumumkan bahawa ia telah diiktiraf oleh PharmaTimes sebagai Syarikat Kajian Klinikal Antarabangsa...
-
미국 노스캐롤라이나주 롤리, May 25, 2018 (GLOBE NEWSWIRE) -- PRA 헬스사이언스(PRA Health Sciences, Inc. (NASDAQ:PRAH))가 5년 연속으로 PharmaTimes로부터 국제지역 올해의 임상기관(International Clinical Research Company of the Year)으로...
-
ノースカロライナ州ローリー発, May 25, 2018 (GLOBE NEWSWIRE) -- PRAヘルス･サイエンシズ (PRA Health Sciences, Inc.、NASDAQ:PRAH) は、ファーマタイムズ (PharmaTimes) によって「年間最優秀国際臨床研究企業 (International Clinical Research Company of the...
-
美國北卡羅來納州羅利, May 25, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc.（NASDAQ:PRAH）十分高興地宣佈，PRA被PharmaTimes評選為年度最佳國際臨床研究公司。這是PRA連續第五年榮獲此稱號。 「該獎項表彰的是臨床研究行業內的卓越表現，而我們有幸再次獲得了同業們的認可，」總裁兼行政總裁Colin...